Last reviewed · How we verify

NCT03760692

I-gel vs Ambu AuraGain in Laparoscopic Gynecological Surgery

Status unknown NA Last updated 28 March 2022
What this trial tests

NA trial testing i-gel in Airway Morbidity in 102 participants. Status unknown.

Timeline
1 November 2018
Primary endpoint
1 November 2024
1 December 2024

Quick facts

Lead sponsorDokuz Eylul University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment102
Start date1 November 2018
Primary completion1 November 2024
Estimated completion1 December 2024
Sites2 locations across Turkey (Türkiye), Spain

Drugs / interventions tested

Conditions studied

Sponsor

Dokuz Eylul University

Who can join

Adults 18 to 65, female only, with Airway Morbidity or Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effects of i-gel and Ambu AuraGain on ventilation parameters and surgical view during Trendelenburg position laparoscopic gynecological surgery in cases administered positive pressure ventilation without the use of neuromuscular agents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of i-gel

Trials testing the same drug.

Other Dokuz Eylul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03760692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing